Literature DB >> 27612471

Adverse effects of isolation: a prospective matched cohort study including 90 direct interviews of hospitalized patients in a French University Hospital.

B Guilley-Lerondeau1, C Bourigault1,2, A-C Guille des Buttes1, G Birgand3,2, D Lepelletier4,5,6.   

Abstract

Isolation precautions in patients with multi-drug resistant bacteria or other communicable infectious agents can be associated with adverse effects. The aim of this study was to assess satisfaction and psychological impact of patients hospitalized with isolation precautions in comparison with controls. An observational prospective cohort study was performed in five different medical and surgical departments in a 3,000-bed university hospital in Western France between March and July 2012. Different scales were used to assess patient satisfaction (qualitative scale) and anxiety (Spielberger scale), including 30 patients with isolation precautions and 60 matched patients without isolation precautions over 45-hour interviews. Cases were significantly less satisfied than controls for healthcare workers (HCW) assistance in activities of daily life (p < 0.001), availability and relationships (17 % vs 5 %, p = 0.05 and 10 % vs 0%, p = 0.02, respectively). Sixty-seven percent of patients with isolation precautions were not satisfied about the quality of the information related to their infectious status control measures. The median score [range] of anxiety significantly was higher in patients with isolation precautions (52 [20-56] vs 31 [23-73], p <0.001). Isolation precautions may have negative psychological effects, leading to anxiety, and may compromise patient satisfaction according to the availability and relationship with HCW. Professionals should be aware of adverse effects of isolation and inform patients more actively with regard to their infectious status and precautions.

Entities:  

Mesh:

Year:  2016        PMID: 27612471     DOI: 10.1007/s10096-016-2772-z

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  15 in total

1.  Adverse effects of contact isolation.

Authors:  K B Kirkland; J M Weinstein
Journal:  Lancet       Date:  1999-10-02       Impact factor: 79.321

2.  Control of drug-resistant pathogens in endemic settings: contact precautions, controversies, and a proposal for a less restrictive alternative.

Authors:  Gonzalo Bearman; Michael P Stevens
Journal:  Curr Infect Dis Rep       Date:  2012-12       Impact factor: 3.725

3.  Involving the patient to ask about hospital hand hygiene: a National Patient Safety Agency feasibility study.

Authors:  D Pittet; S S Panesar; K Wilson; Y Longtin; T Morris; V Allan; J Storr; K Cleary; L Donaldson
Journal:  J Hosp Infect       Date:  2011-01-13       Impact factor: 3.926

4.  Do contact precautions cause depression? A two-year study at a tertiary care medical centre.

Authors:  H R Day; E N Perencevich; A D Harris; S S Himelhoch; C H Brown; A L Gruber-Baldini; E Dotter; D J Morgan
Journal:  J Hosp Infect       Date:  2011-06-12       Impact factor: 3.926

5.  Universal glove and gown use and acquisition of antibiotic-resistant bacteria in the ICU: a randomized trial.

Authors:  Anthony D Harris; Lisa Pineles; Beverly Belton; J Kristie Johnson; Michelle Shardell; Mark Loeb; Robin Newhouse; Louise Dembry; Barbara Braun; Eli N Perencevich; Kendall K Hall; Daniel J Morgan; Syed K Shahryar; Connie S Price; Joseph J Gadbaw; Marci Drees; Daniel H Kett; L Silvia Muñoz-Price; Jesse T Jacob; Loreen A Herwaldt; Carol A Sulis; Deborah S Yokoe; Lisa Maragakis; Matthew E Lissauer; Marcus J Zervos; David K Warren; Robin L Carver; Deverick J Anderson; David P Calfee; Jason E Bowling; Nasia Safdar
Journal:  JAMA       Date:  2013-10-16       Impact factor: 56.272

6.  Contact isolation for infection control in hospitalized patients: is patient satisfaction affected?

Authors:  Leanne B Gasink; Karyn Singer; Neil O Fishman; William C Holmes; Mark G Weiner; Warren B Bilker; Ebbing Lautenbach
Journal:  Infect Control Hosp Epidemiol       Date:  2008-03       Impact factor: 3.254

7.  Do physicians examine patients in contact isolation less frequently? A brief report.

Authors:  Sanjay Saint; Leigh Ann Higgins; Brahmajee K Nallamothu; Carol Chenoweth
Journal:  Am J Infect Control       Date:  2003-10       Impact factor: 2.918

8.  Safety of patients isolated for infection control.

Authors:  Henry Thomas Stelfox; David W Bates; Donald A Redelmeier
Journal:  JAMA       Date:  2003-10-08       Impact factor: 56.272

Review 9.  Adverse outcomes associated with Contact Precautions: a review of the literature.

Authors:  Daniel J Morgan; Daniel J Diekema; Kent Sepkowitz; Eli N Perencevich
Journal:  Am J Infect Control       Date:  2009-03       Impact factor: 2.918

Review 10.  Adverse effects of isolation in hospitalised patients: a systematic review.

Authors:  C Abad; A Fearday; N Safdar
Journal:  J Hosp Infect       Date:  2010-10       Impact factor: 3.926

View more
  4 in total

1.  Patient care experience with utilization of isolation precautions: systematic literature review and meta-analysis.

Authors:  R Nair; E N Perencevich; M Goto; D J Livorsi; E Balkenende; E Kiscaden; M L Schweizer
Journal:  Clin Microbiol Infect       Date:  2020-01-30       Impact factor: 8.067

2.  Impact of isolation on hospitalised patients who are infectious: systematic review with meta-analysis.

Authors:  Edward Purssell; Dinah Gould; Jane Chudleigh
Journal:  BMJ Open       Date:  2020-02-18       Impact factor: 2.692

3.  The Lived Experience of Critically-Ill Muslim Patients in Isolation.

Authors:  Sondos B Eqylan; Reema R Safadi; Valerie Swigart
Journal:  Int J Qual Stud Health Well-being       Date:  2022-12

4.  Higher incidence of adverse events in isolated patients compared with non-isolated patients: a cohort study.

Authors:  Fátima Jiménez-Pericás; María Teresa Gea Velázquez de Castro; María Pastor-Valero; Carlos Aibar Remón; Juan José Miralles; María Del Carmen Meyer García; Jesús Maria Aranaz Andrés
Journal:  BMJ Open       Date:  2020-10-26       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.